827 Streamlining design of safe and effective TCR therapies with AI
Sign Up to like & getrecommendations! Published in 2021 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2021-sitc2021.827
Abstract: Adoptive cell therapies with T lymphocytes expressing engineered T cell receptors (TCRs) are one of the most promising approaches to cancer therapy.1 However, the experimentally driven development of novel TCR therapies is limited by the… read more here.
Keywords: phla tcr; tcr binding; cancer; prediction ... See more keywords